Hangzhou Tigermed Consulting's IPO

Hangzhou Tigermed Consulting raised a round of funding on August 27, 2012. Investors include Public.

Hangzhou Tigermed Consulting (泰格医药) (SHE: 300347) is a Contract Research Organization (CRO) in China dedicated to providing professional full clinical trial services to the pharmaceutical and …

Articles about Hangzhou Tigermed Consulting's IPO: